IMI2 – Call 20 and webinars
A call 20 será lançado já em janeiro de 2020 com tópicos sobre cancro, tuberculose, psoríase, medicamentos baseados em proteínas e vacinas.
Entretanto, as inscrições estão abertas para os webinars, que serão realizados entre 22 a 31 de janeiro de 2020, sobre todos os tópicos da call, assim como sobre as regras e procedimentos do IMI e oportunidades para as PMEs. A inscrição é gratuita, mas obrigatória através da página do webinar.
Os tópicos seguintes estão previstos ser incluídos nesta próxima call:
- Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis
- Innovations to accelerate vaccine development and manufacture
- Tumour plasticity
- Proton versus photon therapy for oesophageal cancer – a trimodality strategy
- Handling of protein drug products and stability concerns
- Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)
This topic is part of the IMI Antimicrobial Resistance (AMR) Accelerator programme.
As datas e os temas de cada um dos webinars previstos são os seguintes:
IMI rules & procedures
- Wednesday 29 January | 11:00
Register
Opportunities for SMEs in IMI2 – Call 20
- Thursday 30 January | 11:00
Register
Topic-specific webinars for IMI2 – Call 20
Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis
Wednesday 22 January | 11:00
Register
Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)
Thursday 23 January | 11:00
Register
Tumour plasticity
Friday 24 January | 11:00
Register
Innovations to accelerate vaccine development and manufacture
Monday 27 January | 11:00
Register
Proton versus photon therapy for oesophageal cancer – a trimodality strategy
Tuesday 28 January | 15:00
Register
Handling of protein drug products and stability concerns
Friday 31 January | 11:00
Register
